Medical research and development company, Medlab Clinical (ASX: MDC) has achieved a record month in cannabis revenue with 846 bottles dispensed in October 2019.
The company witnessed unprecedented increase in demand for NanaBis™, with 735 bottles of NanaBis™ dispensed in October, up 43% over the previous best month.
Two emerging factors differentiating Medlab products include:
- NanaBis status with clinical trials at Royal North Shore Hospital
- More recently allowing doctors and patients to participate via the TGA (Therapeutic Goods Administration) approved Observational Study designed in collaboration with US FDA (Food and Drug Administration).
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.